Increased Risk of Vitamin D Deficiency Among Patients With Non-alcoholic Fatty Liver Disease

2015 ◽  
Vol 110 ◽  
pp. S912-S913
Author(s):  
Alexander Potashinsky ◽  
Sumant Inamdar ◽  
Ashby Thomas ◽  
David Bernstein ◽  
Tai-Ping Lee
Clinics ◽  
2014 ◽  
Vol 69 (8) ◽  
pp. 542-546 ◽  
Author(s):  
M Kucukazman ◽  
N Ata ◽  
K Dal ◽  
AO Yeniova ◽  
A Kefeli ◽  
...  

2013 ◽  
Vol 20 (1) ◽  
pp. 33-37 ◽  
Author(s):  
Cristiana Catena ◽  
Chiara Cosma ◽  
Valentina Camozzi ◽  
Mario Plebani ◽  
Mario Ermani ◽  
...  

2017 ◽  
Vol 36 (1) ◽  
pp. 191-197 ◽  
Author(s):  
Seung Min Lee ◽  
Dae Won Jun ◽  
Yong Kyun Cho ◽  
Ki Seol Jang

2018 ◽  
Vol 1 (3) ◽  
pp. 14-19
Author(s):  
Rachaneeporn Chueansuwan

Vitamin D is increasingly accepted as an important physiological regulator of several organ systems apart from its classical role in skeletal homeostasis. In recent years, new scientific discoveryon vitamin D expands our knowledge of its actions in many aspects such as immune modulation, cell differentiation and proliferation, and inflammatory regulations. Vitamin D deficiency is one of the mostcommon micronutrient deficiencies worldwide. Non-alcoholic fatty liver disease (NAFLD) and vitamin D deficiency often coexist. In addition, epidemiologic evidence has shown that both conditions shareseveral cardio-metabolic risk factors. While pre-clinical experimental data is promising, most clinical trials based on the effect of vitamin D in NASH are under-powered and inconclusive. Further studiesare required to elucidate the beneficial effect of vitamin D or its analogues in NASH. In this article, we provide an overview of the epidemiology and pathophysiology linking NAFLD and vitamin D deficiency,as well as the available evidence on the clinical utility of vitamin D supplementation in NAFLD. Figure 1 แสดงวิตามินดีเมตาบอลิสม์ (ดัดแปลงจากเอกสารอ้างอิง Hossein-Nezhad and Holick (12))


Sign in / Sign up

Export Citation Format

Share Document